Turmeric and Curcumin: Benefits, Best Forms, Dosing, and Side Effects

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Overview

Turmeric is a spice derived from the dried rhizome (underground stem) of the plant Curcuma longa, a member of the ginger family grown commercially in Southeast Asia and India [1][2]. Its primary bioactive compounds are curcuminoids, of which curcumin is the most abundant and well-studied, giving turmeric its characteristic orange-yellow color. The other two curcuminoids in turmeric are demethoxycurcumin and bisdemethoxycurcumin [1].

Turmeric has been used for centuries in Ayurvedic, Chinese, Islamic, and Thai traditional medicine for conditions including indigestion, arthritis, abdominal pain, skin infections, liver disease, and the common cold [2]. Today, oral turmeric and curcumin supplements are promoted for osteoarthritis, depression, allergies, high cholesterol, inflammatory bowel disease, metabolic syndrome, and a wide range of other conditions [2].

The primary mechanism of interest is curcumin's anti-inflammatory activity, which may involve blocking cyclooxygenase-2 (COX-2) — the same enzyme targeted by NSAIDs such as celecoxib (Celebrex) and ibuprofen (Motrin) [1]. Curcumin also demonstrates antioxidant, antimicrobial, and antiproliferative properties in laboratory studies [1][2].

However, a critical challenge with curcumin research must be acknowledged. A widely cited analysis by medicinal chemistry experts raised several concerns: (1) much of curcumin's activity in laboratory experiments may be "false" and only due to interference with assay readouts; (2) regular curcumin is poorly absorbed and unstable; and (3) several well-controlled clinical studies have failed to show benefits [3]. While these points are valid — most positive studies have been small — the analysis largely omitted discussion of bioavailability-enhanced curcumin formulations that address absorption issues and are now the most commonly used types of curcumin supplements [1].

The NIH's National Center for Complementary and Integrative Health (NCCIH) states that conventionally formulated oral turmeric or curcumin is likely safe in recommended amounts for up to 2 to 3 months, but emphasizes that highly bioavailable formulations may harm the liver, and that higher-quality evidence is still needed to reach definitive conclusions about efficacy for most conditions [2].

Forms and Bioavailability

The Core Problem: Poor Natural Absorption

Standard curcumin has extremely low oral bioavailability. When taken with just water, only a small fraction is absorbed into the blood because much of the ingested curcumin is metabolized in the intestine and/or excreted in the stool [1][4]. Unformulated curcumin also has a short half-life of approximately two hours [4]. Because curcumin is lipophilic (fat-soluble), taking it with foods containing fats or oils enhances absorption by stimulating bile production, which aids the absorption of fat-soluble compounds [1][4].

The best way to take a curcumin or turmeric supplement is twice daily (to account for the short half-life), each time with a meal that contains some fat [1]. Most clinical studies use twice-daily dosing [1].

Turmeric Powder vs. Curcumin Extract

Diets high in turmeric spice provide approximately 60 to 100 mg of curcumin per day, well below typical therapeutic doses [1]. Based on laboratory analyses, curcumin accounts for approximately 70% of total curcuminoids in concentrated extracts (standardized to 95% curcuminoids) and approximately 56% of total curcuminoids in products made from root powder [1].

A small study found that when mixed into a high-fat meal, the curcuminoids in turmeric powder (12 grams) were approximately twice as bioavailable as those from freshly grated turmeric (83 grams). Interestingly, both forms raised curcuminoid blood levels far more than curcumin powder (500 mg, 95% curcuminoids) mixed into the same meal, despite all three containing similar amounts of curcumin. The researchers speculated that compounds naturally present in turmeric — such as oils or starches — enhance curcuminoid absorption [5].

Bioavailability-Enhanced Formulations

Due to curcumin's poor natural bioavailability, numerous special formulations have been developed. An independent analysis of bioavailability studies concluded that, compared to unformulated curcumin, relative bioavailability was approximately: NovaSol 185x, CurcuWin 136x, Longvida 100x, Meriva 48x, BCM-95 27x, Curcumin C3 Complex + Bioperine 20x, and Theracurmin 16x [6]. However, these figures should be interpreted cautiously — results for some formulations (Meriva, NovaSol, CurcuWin, Theracurmin) were inflated by including conjugated forms of curcumin that may not be active in the body [1][6].

A subsequent clinical study found that the two formulations that most increased curcumin bioavailability were those that both increased water solubility and promoted incorporation into micelles (tiny fat droplets absorbed through the intestine): micellar curcumin (NovaSol, 57-fold increase) and gamma-cyclodextrin curcumin (Cavacurmin, 30-fold increase). Formulations that only prevented metabolism (piperine) or increased solubility without improving stability during digestion (BCM-95, Longvida, Meriva, Theracurmin) did not significantly improve bioavailability compared to unformulated curcumin in this study [7].

Comparison of Major Formulations

Formulation	Technology	Curcuminoid Content	Relative Bioavailability	Key Notes
Unformulated curcumin (95% extract)	None	~95%	1x (baseline)	Very poor absorption without fat-containing meal [1][4]
C3 Complex + Bioperine (piperine)	Metabolism inhibitor	~95% + 5 mg piperine	~20x	Piperine blocks intestinal and liver metabolism of curcumin [8]
BCM-95	Reconstituted with turmeric oils	~86-88%	~7-27x	Approximately 7x in one study, 27x in independent analysis [6][9]
Meriva	Phosphatidylcholine phytosome	~18% curcuminoids	~29-48x	1,000 mg Meriva = 180 mg curcuminoids. Good clinical data for joint pain and NAFLD [10][11]
Longvida	Solid lipid curcumin particle	~20% curcumin	~100x (free curcumin)	Good short-term cognitive data. Did NOT reduce muscle soreness after exercise [6][12]
Theracurmin	Nanoparticle with gum ghatti	~30% curcumin	~16-27x	60 mg Theracurmin = 18 mg curcumin. Used in Alzheimer's and knee surgery studies [6][13]
NovaSol	Micellar with polysorbate 80	~7% curcumin	~57-185x	Highest bioavailability in multiple comparison studies. Note: polysorbate 80 can cause allergic reactions in dogs [6][7]
CurcuWin	Hydrophilic carrier	~20% curcuminoids	~136x (total curcuminoids)	Half-life 6-7 hours. Used in DOMS studies [6][14]
CurcuWin Ultra+	Encapsulated with polymer matrix	~20% curcuminoids	~98x (total curcuminoids)	Absorbed 40 times faster than regular curcumin [15]
CurQfen	Fenugreek galactomannan fiber	~35-39% curcuminoids	~45x	Extended curcuminoid presence in blood (3.7 hrs vs <1 hr) [16]
Curcugen	Turmeric essential oils + polysaccharides	~50% curcuminoids	~31x	98.5% turmeric-derived [17]

Critical caveat: None of the major comparison studies involved taking supplements along with a high-fat meal. Had they done so, absorption rates across formulations might be more similar to one another and to unformulated curcumin [1]. Laboratory testing of eight popular turmeric supplements found that release was consistently lowest (<10%) under fasted conditions and moderately higher under fed conditions, with the highest release (40%) observed in the fed state for the phytosome formulation (Meriva technology) [18].

Furthermore, formulations demonstrating greater bioavailability based on blood levels have not always shown greater clinical benefit. Longvida, for example, has high measured free curcumin levels but does not appear to reduce muscle soreness or provide long-term cognitive benefit, while Meriva — with lower comparative bioavailability — has shown benefits for muscle soreness, blood sugar spikes, cholesterol, and other outcomes [1].

Piperine (Black Pepper Extract)

Piperine inhibits the metabolism of curcumin in the gut and liver. The commonly cited claim of 20-fold bioavailability increase is based on studies where plain curcumin was given with only water, making the comparison somewhat misleading [8]. A quarter teaspoon of ground black pepper (~500 mg) provides approximately 10-35 mg of piperine, compared to the typical 2.5-5 mg added to curcumin supplements [8]. Piperine may significantly increase the bioavailability of other compounds, including certain medications (see Drug Interactions) [1][8].

Cooking with Turmeric

Some curcumin is lost during cooking. An experiment adding 1 gram of turmeric (33 mg curcumin) to bread, an oat bar, or soup found that each retained, respectively, just 52%, 48%, or 71% of the original curcumin after cooking [19]. Adding black pepper to turmeric-containing foods can increase curcumin bioavailability, and consuming such foods as part of a fat-containing meal further aids absorption [1][19].

Turmeric tea provides negligible curcumin — a typical tea bag contains 750-1,000 mg of turmeric powder (only 11-15 mg of curcumin), and the tea bag itself may filter out as much as 99% of that curcumin, leaving less than 1 mg in the drinkable tea [1].

Fermented Turmeric

There is no strong evidence supporting claims of increased bioavailability from fermented turmeric. A rat study showed only an 11% increase in plasma antioxidant concentration compared to unfermented turmeric, and laboratory research found fermentation increased curcumin concentration by just 10% [1].

Evidence for Benefits

Osteoarthritis

Osteoarthritis is the condition with the most clinical evidence supporting curcumin use. Several short-term (6 to 12 week) studies focusing mainly on knee osteoarthritis have shown generally modest reductions in pain, with less consistent improvement in function [1][2].

Curcuminoids plus Bioperine (1,500 mg/day): A placebo-controlled study of people with mild to moderate knee osteoarthritis found that 1,500 mg of a curcuminoid complex (500 mg three times daily with 5 mg Bioperine) for six weeks significantly reduced osteoarthritis symptom severity, with particular reductions in pain and improvements in physical function compared to placebo. Participants receiving curcumin reduced their anti-inflammatory drug use by 84% versus 19% in the placebo group [20].

BCM-95 curcumin (1,000 mg/day): Taken as 500 mg capsules (333 mg curcuminoids each) three times daily for 12 weeks in Armenia, BCM-95 modestly reduced pain-related symptoms of knee osteoarthritis compared to placebo. Physical performance improvements were somewhat greater when combined with a Boswellia extract [21].

Low-dose turmeric extract (187-280 mg/day): A study among 101 men and women in Belgium with moderate knee osteoarthritis found that both 187 mg and 280 mg daily of turmeric root extract (formulated with polysorbate 80 for enhanced absorption) for three months significantly decreased pain compared to placebo. Pain decreased by 8 points on a 100-point scale with placebo versus 29.5 and 36.5 points with the low and higher doses, respectively. Statistically, there was no difference between the two active doses, although the higher dose caused more GI side effects [22].

CurcuWin Ultra+ (250-500 mg/day): A study among 134 men and women in India with mild knee osteoarthritis found that both 250 mg and 500 mg daily of a bioavailability-enhanced curcumin extract for 12 weeks significantly reduced knee pain and improved function compared to placebo, with the higher dose showing greater benefit. Pain decreased by approximately 20% (low dose) and 35% (high dose) compared to baseline, while placebo showed no significant decrease. Walking distance during a treadmill test increased by 32 yards (low dose) and 60 yards (high dose) versus no improvement with placebo [23].

Curcugen (500 mg/day): A study among 98 men and women (average age 59) in Australia found that 250 mg curcuminoids from Curcugen twice daily for eight weeks modestly reduced self-reported knee pain compared to placebo (37% of curcumin users had clinically meaningful pain reduction versus 9% with placebo). However, supplementation did not significantly improve stiffness, function, or quality of life [24].

Added to existing NSAID therapy: In patients already taking diclofenac (50 mg/day) plus omeprazole, adding 500 mg curcumin (95% extract) for two months provided only slightly better pain improvement (score fell from 15 to 9.5 vs. 15 to 10.2 with placebo). The curcumin group had greater decreases in markers of oxidative stress but not inflammation, and neither group showed knee joint improvements on X-ray [25].

Negative finding in obese, sedentary individuals: Curcumin alone or combined with fish oil did NOT reduce joint pain in a placebo-controlled study of sedentary, obese men and women with mild, chronic osteoarthritis pain in the knees, lower back, or shoulders [26].

Turmeric polysaccharides (without curcumin): A study using a turmeric extract containing polysaccharides but no curcumin (500 mg twice daily) found it performed better than placebo and chondroitin sulfate in people with knee osteoarthritis, suggesting other turmeric constituents may also be active [27]. A separate study using turmeric polysaccharides with curcuminoids (1,000 mg daily, providing 800 mg polysaccharides and 200 mg curcuminoids) found modest improvement in pain over 12 weeks but no significant reduction in joint swelling on MRI compared to placebo [28].

Post-surgical: In a study of patients after knee surgery, curcumin (180 mg/day as Theracurmin) for one year did not reduce self-reported pain compared to placebo, but did modestly reduce cartilage stiffness and roughness based on arthroscopic imaging [29].

Meta-analyses: Several meta-analyses of RCTs have evaluated curcumin for knee osteoarthritis, finding generally positive initial evidence for pain relief, though the NCCIH states that higher-quality evidence is still needed to reach definitive conclusions [2][30][31][32].

Rheumatoid Arthritis

Curcumin may help treat symptoms of rheumatoid arthritis but is not superior to NSAIDs and does not appear to maintain or prolong remission.

BCM-95 vs. diclofenac (1,000 mg/day): A study found 500 mg twice daily of BCM-95 was comparable to a low dose (50 mg) of diclofenac twice daily after 8 weeks, with symptoms reduced by approximately 40%. Combining curcumin and diclofenac was no more effective than either alone, though the study lacked a placebo control [33].

Curcumin as adjunct (475 mg/day): Among 44 women with moderately active rheumatoid arthritis (all on prednisolone, most on methotrexate and/or hydroxychloroquine), 500 mg turmeric extract (95% curcumin) daily for 8 weeks reduced the number of tender or swollen joints from approximately 5 to 1 — statistically significant versus placebo. Joint pain decreased by 45 points (0-100 scale) compared to a 3.63-point reduction in the placebo group, and disease activity decreased by 1.69 points (0-10 scale) versus 0.05 with placebo [34].

High-dose curcumin (1,200 mg/day): An older study found 1,200 mg curcumin reduced symptoms, but not as effectively as the NSAID phenylbutazone [35].

For maintaining remission: Curcumin (1,000 mg plus 5 mg piperine twice daily) did NOT help maintain or prolong flare-free remission in a study of 185 men and women who tapered their standard DMARDs over one year. A similar percentage remained in remission in both groups (60% placebo vs. 64% curcumin), and median days until flare was also similar [36].

Back Pain

Several studies suggest turmeric-boswellia combinations may reduce acute and chronic low-back pain in the short term, though it is unclear whether the benefit is from turmeric, Boswellia, or the combination.

Acute low-back pain: A single 1,000 mg dose of a turmeric-boswellia formulation (266 mg curcuminoids + 10 mg AKBA) reduced pain at rest by 8.2 points (0-10 scale) after 6 hours compared to baseline, significant versus placebo. Approximately 93% achieved complete pain relief after 6 hours compared to none with placebo [37].

Posture-related pain: Taking 500 mg of the same formulation daily for 15 days reduced pain intensity by 56% after 7 days and 98.5% after 15 days, with significant reductions in functional disability (98%) compared to placebo (3% improvement) [38].

Chronic low-back pain: A 3-month study using 300 mg of a different turmeric-boswellia formulation modestly reduced pain intensity by 2.79 points (0-20 scale) and pain unpleasantness by 3.62 points versus placebo [39].

Gastrointestinal Conditions

Indigestion (Functional Dyspepsia)

Several small, short-term studies suggest curcumin may slightly to modestly reduce symptoms of indigestion:

• Turmeric vs. placebo: 500 mg four times daily for 7 days showed 87% improvement vs. 53% with placebo in 116 participants [40].
• Curcumin vs. omeprazole: 500 mg curcumin four times daily showed similar modest pain reductions to omeprazole 20 mg daily (17-point vs. 15-point decrease on a 47-point scale) after one month, both significant vs. placebo (10-point decrease). Curcumin also significantly reduced gas, bloating, and nausea compared to placebo [41].
• Another curcumin vs. omeprazole study: Among 206 people, curcumin (500 mg four times daily) and omeprazole (20 mg daily) showed comparable, small reductions in pain and non-pain symptoms, with no additional benefit from combining them [42].
• Curcugen for digestive symptoms: 500 mg daily for two months only slightly reduced overall symptom scores compared to placebo (0.81 vs. 0.47 point decrease on a 7-point scale) with no improvement in any specific symptom [43].

Ulcerative Colitis

Curcumin may be helpful as an adjunct to standard medication for ulcerative colitis, though results vary by formulation and dose:

• High-dose curcumin (3 g/day) for active UC: 1.5 g curcumin twice daily plus mesalamine for one month achieved remission in 53.8% of patients versus 0% with placebo — a striking result [44].
• Nanomicelle curcumin (240 mg/day): 80 mg three times daily plus mesalamine for one month modestly decreased urgency and improved well-being, but did not decrease blood in stool or colitis-related skin ulcers [45].
• Maintenance of remission: 1 g curcumin twice daily plus mesalamine or sulfasalazine for six months helped maintain remission [46], but a lower dose (450 mg/day) did not improve remission rates or mucosal healing [47].
• Crohn's disease: A double-blind RCT found 3,000 mg curcumin (2,850 mg curcuminoids) daily for six months was no more effective than placebo in preventing Crohn's recurrence after bowel resection. In fact, 55% of the curcumin group had severe recurrence versus 26% with placebo [48].

Familial Adenomatous Polyposis

A preliminary study in 5 people suggested curcumin might cause regression of intestinal polyps. However, a 12-month clinical study using 1,500 mg pure curcumin twice daily found no significant difference in polyp number or size versus placebo. The earlier positive study used a lower dose of curcumin (480 mg three times daily) but included black pepper extract and quercetin (20 mg per dose) [49].

Other GI Conditions

Results for gastric or duodenal ulcers are conflicting — at least two studies found no benefit while a third found symptom improvement [1].

Muscle Soreness and Recovery After Exercise

Results are mixed. At best, curcumin taken for a few days before intense exercise may slightly reduce resulting inflammation, and taken after exercise may reduce muscle damage and soreness.

Positive findings:

• Theracurmin (90 mg/day): Did not reduce soreness when taken for 7 days before exercise, but when taken for 7 days after exercise, significantly reduced muscle soreness and improved muscle strength and range of motion starting 3-6 days post-exercise. It also reduced creatine kinase (muscle damage marker) but not inflammation markers [50].
• Meriva (200 mg curcumin/day): Taken at breakfast and dinner for 4 days, significantly reduced thigh soreness 48 hours after intense treadmill exercise compared to placebo [51].
• High-dose curcumin (5,000 mg/day): Taken 2 days before and 3 days after intense leg exercise, moderately reduced leg pain at 24 and 48 hours, but effects on inflammation markers were inconclusive [52].
• CurcuWin (200 mg curcuminoids/day): Taken for 2 months, significantly reduced thigh soreness 24 hours after muscle-damaging exercise vs. placebo. A lower dose (50 mg curcuminoids) reduced muscle damage markers but did not significantly decrease soreness [53].
• Standard curcumin (950 mg curcuminoids/day): 500 mg twice daily starting 6 days before and continuing 3 days after high-intensity exercise modestly decreased muscle soreness up to 3 days after exercise and maintained muscle power (vs. power loss in placebo group), but did not reduce blood markers of muscle damage or inflammation [54].

Negative findings:

• Longvida (80 mg curcumin/day): Did not reduce muscle soreness compared to placebo, though it somewhat reduced inflammation markers [55].
• High-dose curcumin + piperine (6,000 mg + 60 mg piperine/day): Did not limit muscle damage or soreness and only slightly limited sprint power loss [56].

Turmeric polysaccharides (without curcumin): 2,000 mg daily for 7 days slightly increased the time until discomfort during stair climbing by 32 seconds and slightly decreased knee pain after exercise by 0.93 cm (on a 10-cm scale), but changes were not clinically meaningful and there was no placebo control [57].

Memory, Cognition, and Alzheimer's Disease

Short-term cognitive benefits have been observed, but longer-term studies show mixed results [1].

Positive short-term findings:

• Longvida (80 mg curcumin/day): In healthy adults aged 60-85, one hour after the first dose, subtraction test scores improved by 16% (vs. 2% with placebo). After 4 weeks, scores improved by 17% (vs. 3%) and fatigue reduced by 11% (vs. 4%). However, no benefits were found on word or picture recall tests [12].
• Turmeric powder (1 g) and pre-diabetes: In people aged 60+ with pre-diabetes, scores on a number recall test improved from 2.6 to 2.9 (out of 3.0) six hours after a single dose, with no improvement in placebo. Interestingly, the turmeric had no effect on blood sugar or insulin [58].
• Theracurmin (180 mg/day): In 40 older adults (normal cognition or mild cognitive impairment), 90 mg twice daily for 18 months modestly improved short-term memory, verbal memory, and attention compared to placebo. PET scans showed the placebo group had slight increases in amyloid beta plaque and tau tangles that were not seen in the curcumin group, though the clinical significance is unclear [59].

Negative longer-term findings:

• Longvida (2,000 mg/day): In 39 healthy adults (ages 45-74), 400 mg curcumin daily for 3 months showed no significant improvement in cognitive function, fatigue, or motor function compared to placebo. Unlike the positive study, Longvida was taken without food [60].
• Longvida (160 mg curcumin/day): After 16 weeks, did not improve blood flow to the brain in sedentary, obese older adults [26].
• BCM-95 (1,500 mg/day): In older adults with normal cognitive function, 500 mg three times daily for 12 months had no beneficial effect on cognitive function, mood, or quality of life. A notably high 26% dropout rate due to GI side effects was observed, compared to 4% with placebo [61].

Alzheimer's disease trials: Results have been disappointing. Curcumin given to Alzheimer's patients did not significantly improve mental functioning compared to placebo in several trials [62][63], although 100 mg/day for 3 months was reported to reduce agitation, anxiety, and irritability in 3 people with severe Alzheimer's who were also taking an acetylcholinesterase inhibitor [64]. A review of the evidence concluded that studies in people "have not been able to generate the anticipated benefits of curcumin," possibly due to low bioavailability and disease severity in participants [65].

Depression

Curcumin may help treat depression, though effects typically take 4-12 weeks to manifest and appear more pronounced in atypical depression [1].

BCM-95 as adjunct to antidepressants: In people with major depression (on pharmaceutical antidepressants), 500 mg BCM-95 twice daily showed no advantage over placebo at 4 weeks, but from weeks 4 to 8, curcumin was significantly more effective. Greater efficacy was noted in atypical depression [66]. A subsequent larger study found that a lower dose (250 mg twice daily) taken for 3 months was as effective as 500 mg twice daily, with benefits emerging after the first 4 weeks [67].

Curcuminoid escalation with antidepressants: In adults already taking antidepressants, curcuminoids starting at 500 mg/day and escalating to 1,500 mg/day over 3 weeks, then maintained for 8 more weeks, significantly improved depression symptoms at 12 weeks compared to placebo [68].

Long-term in diabetic adults with depression: Among 227 obese adults with type 2 diabetes and moderate to moderately severe depression (not on antidepressants), 1,500 mg curcuminoids daily for 12 months reduced depression severity by at least one stage in 20.4% versus 2.6% with placebo [69].

Negative finding — postmenopausal women: 500 mg curcumin twice daily for 8 weeks did not improve depression scores compared to placebo in postmenopausal women with self-reported mild depression (without clinical diagnosis) [70].

Insulin Resistance and Diabetes

In healthy people: Taking 180 mg curcumin (as Meriva) immediately before a carbohydrate-containing breakfast reduced the post-meal blood sugar spike by 61% and insulin spike by 26% compared to placebo in 15 healthy young adults [71].

Insulin resistance: In 29 adults with insulin resistance, 1,000 mg Meriva (180 mg curcumin) daily for 3 months significantly reduced insulin resistance (HOMA2-IR decreased by 0.3 vs. slight increase with placebo) and also reduced blood levels of compounds associated with both diabetes and Alzheimer's development (GSK-3 and IAPP) [72].

Prediabetes prevention: In a landmark 9-month study, none of 97 middle-aged, slightly overweight Thai subjects taking 1.5 g curcuminoids daily became diabetic, compared to 19 of 104 subjects receiving placebo. Curcumin appeared to boost insulin-secreting cell activity [73].

Type 2 diabetes — mixed results:

• Theracurmin 180 mg/day (54 mg curcumin) for 6 months did not lower HbA1c versus placebo in 33 people with impaired glucose tolerance or type 2 diabetes [74].
• Curcumin 500 mg/day (with 5 mg piperine) for 4 months produced a slight but significant HbA1c decrease but no improvement in fasting blood sugar, insulin, or HOMA-IR in 61 people with type 2 diabetes [75].
• Curcuminoids 1,500 mg/day for 12 months in 229 adults with type 2 diabetes on metformin showed modest but significant reductions in HbA1c (-0.16%), fasting blood sugar (-8.16 mg/dL), insulin (-1.42 uU/mL), and insulin resistance (HOMA-IR: -0.36), with improvements sometimes taking 6-9 months to reach statistical significance versus placebo [76].

Cardiovascular risk in diabetics: A 14-week study among 72 adults with type 2 diabetes found that 1,500 mg turmeric daily did not significantly improve blood sugar but did reduce systolic BP (-5.2 vs. +1.5 mmHg), diastolic BP (-9.5 vs. -2.1 mmHg), and LDL cholesterol (-39.9 vs. -12.5 mg/dL) versus placebo, though the study was not blinded [77].

Fatty Liver Disease (MASLD/NAFLD)

Several short-term studies suggest curcumin supplementation improves liver health markers in people with metabolic dysfunction-associated steatotic liver disease (MASLD), though not all studies agree [1][2].

Positive findings:

• Curcumin 500 mg/day for 5.5 months (China): Decreased liver fat by 4.2% (vs. 1.7% increase with placebo), with modest improvements in ALT, body weight, triglycerides, fasting blood sugar, and HbA1c [78].
• C3 Complex 500 mg/day + Bioperine for 3 months (Iran): Significantly decreased ALT, AST, and ALP liver enzymes and disease severity scores, though not cholesterol or blood sugar measures [79].
• C3 Complex 500 mg/day + Bioperine for 12 weeks (Iran): Decreased ALT and AST, with modest decreases in triglycerides (-28 mg/dL), total cholesterol (-22 mg/dL), and LDL (-14 mg/dL). Did not decrease liver fibrosis [80].
• Meriva 2,000 mg/day for 15 months (Italy, NASH patients): In advanced disease, resolved inflammation and prevented worsening of liver scarring in 62% versus 12% with placebo. NAFLD activity score improved by 2.81 points (0-8 scale) vs. 0.76 with placebo. Additionally, 13 of 16 patients with concurrent chronic kidney disease showed CKD regression [81].

Negative finding: In 36 obese subjects in Denmark, 1,000 mg phytosomal curcumin (Meriva) twice daily for 6 weeks did not decrease liver fat, BMI, or visceral fat compared to placebo [82].

Multiple meta-analyses of RCTs support modest benefits for liver enzymes and some metabolic markers in NAFLD, though conclusions are limited by heterogeneous study designs [83][84][85][86].

Cholesterol

Evidence is mixed. Curcumin formulations with enhanced bioavailability have generally shown better results than regular turmeric powder or curcumin, though even enhanced formulations are far less effective than statin medications [1].

No benefit with regular curcumin: A 2014 review failed to find a beneficial effect on cholesterol from turmeric or curcumin [87]. An 8-week study of 1 g curcumin (with or without probiotics) in overweight adults with metabolic syndrome on a calorie-restricted diet also showed no benefit [88].

Modest benefit with enhanced formulations: A 2017 review indicated that turmeric and curcumin can modestly lower elevated LDL cholesterol and triglycerides, with enhanced bioavailability formulations being more effective, particularly for triglycerides [89]. Adding 1,000 mg Meriva daily to phytosterol supplementation for one month decreased total and LDL cholesterol by 11% and 14.4% (vs. 4.8% and 8.1% with phytosterol alone); Meriva alone showed only slight, non-significant decreases [90].

Comparison with statin: 4,500 mg/day of bio-enhanced turmeric (with Bioperine) for 4 weeks was significantly less effective than rosuvastatin 5 mg at reducing LDL cholesterol (-36.6% with rosuvastatin vs. minimal change with turmeric) [91].

Blood Pressure

Postmenopausal women: A daily dose of 150 mg curcumin (as Theracurmin) for 2 months significantly lowered systolic blood pressure by approximately 5 points (but not diastolic) in healthy, sedentary postmenopausal women — comparable to the effect of an aerobic exercise program [92].

Lupus nephritis: 500 mg turmeric (22.1 mg curcumin) taken with each meal (total 66.3 mg curcumin/day) for 3 months significantly reduced systolic blood pressure in lupus patients with kidney inflammation taking corticosteroids and/or antihypertensives [93].

Weight Loss

A review of 11 placebo-controlled RCTs in adults with pre-diabetes, obesity, metabolic syndrome, or NAFLD found that curcumin had a modest but significant effect on body weight (average loss of 2.5 lbs) over studies of 3-12 weeks. Waist circumference decreased by 1-1.5 inches, but only in overweight people taking at least 1,000 mg/day for at least 8 weeks [94].

However, curcumin (1,000 mg, with or without 10 mg piperine) daily for 12 weeks without changes to diet or activity did not decrease body weight or BMI in overweight people with inflammatory bowel disease, though there was a slight increase in lean muscle mass in the curcumin + piperine group [95].

Cancer

Curcumin suppresses proliferation of many cancer cell types in laboratory settings, but clinical evidence in humans is limited [1].

Colon cancer prevention: In 64 adult smokers, 4 g curcumin daily for 30 days reduced aberrant crypt foci (potential precancerous colon changes) by 39%. A 2 g dose was not effective [96].

Myeloma precursors (MGUS/SMM): In 18 people, 8 g curcumin daily for 3 months decreased serum free light-chain ratio (a risk factor for disease progression) by approximately 37% in those with abnormal ratios [97]. Another study using 4-8 g daily for up to one year reduced certain inflammatory markers and a myeloma growth-promoting protein, though without clinical improvements [98]. A case report described a 57-year-old woman with stage 3 myeloma no longer responding to treatment who maintained stable disease for 5+ years taking 8 g curcumin daily with Bioperine plus weekly hyperbaric oxygen [99].

Pancreatic cancer: In 21 patients taking 8 g curcumin daily, only 2 showed a positive biological response [100].

Prostate cancer: In 44 men with metastatic castration-resistant prostate cancer on chemotherapy, 6,000 mg curcumin daily for 6 months did not improve progression-free or overall survival, PSA response rate, or quality of life versus placebo [101].

Oral mucositis (cancer treatment side effect): Initial research suggests turmeric or curcumin in oral or mouthwash formulations may improve symptoms of oral mucositis related to cancer treatment [2][102][103][104].

Eye Disease

Dry eye: A study among 116 people with moderate dry eye found that a combination supplement containing curcumin (200 mg curcuminoids), lutein (20 mg), zeaxanthin (4 mg), and vitamin D3 (600 IU) daily for 8 weeks increased tear production by 67% (vs. 3% with placebo) and reduced dry eye severity by 57% (vs. 13% with placebo). However, tear production did not reach normal ranges and need for artificial tears was not reduced [105].

Age-related macular degeneration (AMD): In a large observational study of nearly 181,000 adults, turmeric/curcumin supplement users were 77-89% less likely to develop any type of AMD and 54% less likely to have gone blind than non-users, though this does not prove causation [106].

Chronic anterior uveitis: A study found that 600 mg Meriva twice daily for one year reduced symptoms of eye discomfort and decreased relapses from 275 per year to 36, though there was no placebo control [107].

Allergies (Seasonal Rhinitis)

In over 200 people with seasonal allergy in China, 500 mg curcumin daily for 2 months significantly improved sneezing, runny nose, and nasal congestion, with total symptom scores falling from 8 to 2.8 (out of 12) versus no significant changes with placebo. Curcumin also decreased inflammatory mediators including IL-4 and TNF-alpha [108].

Common Cold

A study among 94 healthy people found that 150 mg/day curcumin (as Theracurmin) for 12 weeks reduced the number of days experiencing cold symptoms by approximately 17-18 days compared to placebo. The newer formulation (Theracurmin Super) specifically reduced days of sneezing (-10.5), runny nose (-14.5), stuffy nose (-11.2), and cough (-6.4) versus placebo [109].

Postmenopausal Health

In 64 postmenopausal women, curcumin 500 mg twice daily for 8 weeks slightly improved self-reported musculoskeletal health (by 5.3 points on a 0-56 scale) and fatigue (by 2.6 points on a 0-39 scale) compared to placebo, but neither difference was considered clinically meaningful [70].

Asthma

In children and adolescents with persistent moderate asthma on standard medications, daily curcumin (~20-40 mg curcuminoids, dose adjusted by weight) for 6 months decreased nighttime awakenings and short-acting inhaler use, and improved disease control versus placebo [110].

Gout

Despite laboratory evidence suggesting curcumin may inhibit xanthine oxidase (the enzyme that produces uric acid) and a kidney urate transporter, 500 mg curcumin twice daily for 8 weeks did not reduce blood urate levels or increase urinary urate excretion compared to placebo in 39 people with persistent hyperuricemia [111].

Parkinson's Disease

In 42 people with mild to severe Parkinson's disease stabilized on standard treatments, 80 mg nanomicelle curcumin daily for 9 months did not improve motor or non-motor symptoms or quality of life versus placebo [112].

Psoriasis

A clinical trial with a curcuminoid complex (4,500 mg/day) showed a low response rate in psoriasis [113].

Reducing Salt Intake

Approximately 300 mg (1/6 teaspoon) of turmeric combined with 900 mg salt made food taste almost as salty as 2,400 mg of salt alone. The effect is attributed to eugenol, an odorous compound found in turmeric and other spices [114].

Recommended Dosing

Optimal doses of curcumin have not been established and vary considerably depending on the condition, formulation, and bioavailability enhancement [1]. The following table summarizes dosages used in clinical studies:

Dosage by Condition

Condition	Dosage	Duration	Formulation	Key Study
Indigestion	500 mg turmeric powder 4x/day (2 g/day)	7 days	Regular turmeric	[40]
Ulcerative colitis (active)	1,500 mg curcumin 2x/day (3 g/day)	1 month	95% curcumin extract	[44]
UC (maintenance)	1 g curcumin 2x/day (2 g/day)	6 months	Standard curcumin	[46]
Knee osteoarthritis	500 mg curcuminoids 3x/day (1,500 mg/day)	6 weeks	C3 Complex + Bioperine	[20]
Knee OA (low-dose)	187-280 mg turmeric extract/day	3 months	Enhanced absorption	[22]
Rheumatoid arthritis	500 mg BCM-95 2x/day (1,000 mg/day)	8 weeks	BCM-95	[33]
Depression	250-500 mg BCM-95 2x/day	8-12 weeks	BCM-95	[66][67]
Prediabetes prevention	750 mg curcuminoids 2x/day (1,500 mg/day)	9 months	Standard curcuminoids	[73]
Blood sugar (after meals)	180 mg curcumin (from 1 g Meriva)	With meal	Meriva	[71]
NAFLD	500 mg curcumin/day (+ 5 mg Bioperine)	3 months	C3 Complex	[79]
Muscle soreness prevention	200 mg curcumin (from 1 g Meriva) 2x/day	2 days before + day of exercise	Meriva	[51]
Cognition (short-term)	80-400 mg curcumin/day	4 weeks	Longvida	[12]
Memory (long-term)	90 mg Theracurmin 2x/day (180 mg/day)	18 months	Theracurmin	[59]
Seasonal allergy	500 mg curcumin/day	2 months	Standard	[108]
Colon cancer prevention	4,000 mg curcumin/day	30 days	Micronized 98%	[96]
Blood pressure	150 mg curcumin/day (as Theracurmin)	2 months	Theracurmin	[92]

General Dosing Principles

• Take with a fat-containing meal to maximize absorption of all formulations [1][4].
• Split into twice-daily doses due to curcumin's short half-life (~2 hours for standard curcumin) [1][4].
• Bioavailability-enhanced formulations require lower doses than standard curcumin or turmeric powder to achieve therapeutic blood levels [1].
• Standard turmeric root powder: 3-12 g/day (providing ~90-360 mg curcumin). Volumes above 8 g/day may be impractical [1].
• Standard curcumin extract (95%): 500-2,000 mg/day in divided doses.
• Enhanced bioavailability formulations: Effective doses range from 80 mg (Longvida, short-term cognition) to 1,000 mg (Meriva, NAFLD/insulin resistance), depending on the formulation's enhancement factor [1].
• Start with a lower dose to reduce the risk of GI side effects, particularly with higher-potency formulations [22].

How to Read a Supplement Label

When comparing products, pay attention to:

• The weight of the total formulation vs. the weight of curcuminoids — e.g., 1,000 mg Meriva contains only 180 mg curcuminoids [10].
• Whether the product lists total curcuminoids or just curcumin (curcumin is ~70% of total curcuminoids in concentrated extracts) [1].
• Whether a bioavailability enhancer is included (piperine/Bioperine, phospholipids, etc.).

Safety and Side Effects

General Safety

Turmeric products are believed to be generally safe for short periods at doses up to 8,000 mg/day of curcumin, based on cancer studies lasting up to 18 months [100][115]. However, formal long-term safety studies have not been conducted [1][2].

The NCCIH states that conventionally formulated oral turmeric or curcumin (not modified to enhance bioavailability) is "likely safe in the recommended amounts for up to 2 or 3 months" [2].

Common Side Effects

• Nausea, diarrhea, and abdominal discomfort are the most frequently reported [1][2][115]
• Yellow stool
• Headache
• Allergic skin reactions (oral use); hives or itching (topical use) [2]
• Increases in serum alkaline phosphatase and lactate dehydrogenase [115]

GI side effects may be dose-dependent. In one study using BCM-95 (1,500 mg/day), 26% of participants dropped out due to GI side effects vs. 4% with placebo [61]. Starting with a lower dose may reduce this risk [22].

Liver Injury

This is the most serious safety concern. Even though curcumin is studied for fatty liver disease treatment, it can paradoxically cause liver injury in some individuals [1][2].

Incidence: A review of 20 clinical trials found a 5% overall incidence of abnormal liver function when curcumin supplementation lasted longer than one month [116].

DILIN cases: A review of 10 cases reported to the U.S. Drug Induced Liver Injury Network (DILIN) between 2004-2022 found [117]:

• 8 of 10 cases were women; average age 56
• Average duration of use before injury: ~12 weeks
• 43% of products tested contained piperine
• Symptoms: jaundice, nausea, abdominal pain
• Severity: mild (50%), moderate (40%), fatal (1 case)
• 7 of 10 carried the HLA-B*35:01 genetic variant, also linked to liver injury from green tea, Garcinia cambogia, and Fo-ti

Additional case review: An analysis of 11 other U.S. cases (2012-2022) found 91% were female (average age 58), duration before injury ranged from 2 weeks to 13 months (average 8 weeks), and dosage ranged from 100-3,000 mg/day. More than half were asymptomatic, identified only by abnormal liver tests. All but one showed 50% improvement within 30 days of discontinuation [118].

Population exposure: A study estimated the exposure to potentially hepatotoxic botanicals in U.S. adults, identifying turmeric/curcumin as one of the most commonly used supplements with liver injury reports [119].

NCCIH warning: "Many curcumin products with increased bioavailability are on the market, and liver damage has been reported in some people who have consumed these bioavailable formulations" [2].

Warning signs: Fatigue, nausea, poor appetite, dark urine, jaundice (yellowing of skin/eyes), or pale stools. Stop supplementation immediately and consult a healthcare provider if any occur [2][117].

Drug interaction risk: Use of GLP-1 agonists (e.g., semaglutide/Ozempic) may increase liver injury risk from turmeric, as GLP-1 drugs slow intestinal transit and could increase curcumin absorption [120].

Gallbladder Effects

Even small doses of curcumin (20-80 mg) can stimulate gallbladder contractions and could increase pain during stone passage or potentially increase perforation risk in people with gallstones [121]. However, turmeric does not contribute to gallstone formation [1].

Kidney Stones

Turmeric contains substantial oxalate (~20 mg per gram of turmeric powder). A daily dose of 2.8 g turmeric powder significantly increased urinary oxalate levels over 4 weeks [122]. People prone to calcium oxalate kidney stones should limit turmeric intake. Some curcumin extracts (BCM-95, Meriva, C3 Complex) claim to be essentially free of oxalates (<0.025 mg per 500 mg dose), as oxalate is likely removed during extraction [1].

Yellowing of Skin

Rarely, turmeric consumption can cause yellow skin discoloration without liver injury. This has been reported with high dietary turmeric intake and with standard supplement doses, resolving after discontinuation [123][124].

Lowering Iron Levels

Curcumin may bind iron and reduce its availability. A case report described iron deficiency anemia developing 3 months after starting high-dose turmeric supplementation, which resolved within 2 weeks of stopping [125]. However, a controlled trial found that 500 mg bioavailability-enhanced curcumin taken 60 minutes after iron supplementation did not diminish iron absorption [126]. As a precaution, people with anemia or marginal iron stores should avoid taking curcumin simultaneously with iron and may want to separate them by at least 60 minutes [1].

Tooth Staining

Turmeric can stain teeth and dental work. The American Dental Association says there is no evidence that turmeric has a whitening effect. Staining risk is greatest after dental procedures that increase tooth surface roughness (etching, bonding, whitening) [127].

Pregnancy and Nursing

Safety has not been well evaluated. Turmeric supplements are not recommended for pregnant or nursing women, or those who may become pregnant [1][2].

Drug Interactions

Anticoagulants and Antiplatelet Drugs

Avoid combining turmeric/curcumin supplements with blood thinners including aspirin, clopidogrel (Plavix), warfarin (Coumadin), and rivaroxaban (Xarelto). Curcumin has anticoagulant and antiplatelet activity in laboratory studies, and 2.5 g turmeric daily for 5 days significantly slowed blood clotting time in a woman on fluindione (oral anticoagulant) [128]. Turmeric may also increase bleeding risk during surgical procedures — some experts recommend stopping supplementation 3-5 days (or up to 2 weeks) before any procedure with bleeding risk [129].

Blood Sugar-Lowering Medications

Curcumin may enhance the blood sugar-lowering effect of diabetes medications. Taking 475 mg/day curcumin enhanced the effect of glyburide in type 2 diabetes [130]. Use caution with insulin, glyburide (DiaBeta), pioglitazone (Actos), and rosiglitazone (Avandia).

CYP3A4 Enzyme Interactions

Curcumin may interfere with the CYP3A4 enzyme system that metabolizes many drugs, potentially increasing or decreasing their blood levels:

Drugs with increased levels (potentially dangerous):

• Tacrolimus — A case report described dangerously elevated drug levels and kidney damage in a liver transplant patient consuming large amounts of turmeric (~75 g/day). Resolved after eliminating turmeric and temporarily withholding tacrolimus [131].
• Bortezomib (Velcade) — Reported increased toxicity including constipation, decreased red blood cells, peripheral nerve pain [132].
• Other CYP3A4 substrates that could theoretically be affected (no reported cases): midazolam, fentanyl, lidocaine, losartan, fexofenadine (Allegra), omeprazole (Prilosec), ondansetron (Zofran), felodipine (Plendil), amlodipine (Norvasc), diltiazem, nicardipine, verapamil, rifampin, and oral estrogen [1].

Drugs with decreased levels:

• Everolimus — Two cases of significantly decreased blood levels at curcumin doses as low as 12 mg with 0.3 mg piperine, resolving after curcumin discontinuation [133].
• Tamoxifen — High-dose curcumin (3,600 mg/day) decreased tamoxifen absorption by 8% (12.8% with piperine) and significantly decreased endoxifen levels, potentially below the efficacy threshold for 20-40% of patients [134].
• Talinolol — Some evidence curcumin may decrease bioavailability of this beta-blocker [135].

Sulfasalazine

Curcumin may increase the effects of this anti-inflammatory drug [136].

Testosterone (Oral)

Curcumin can increase blood levels of oral testosterone (testosterone undecanoate) by improving gut absorption through inhibition of the enzyme UGT2B17. In a study, 630 mg curcumin increased testosterone bioavailability by approximately 50% and maximum blood level by 80% over 6 hours [137].

Piperine Interactions

Piperine (black pepper extract) in curcumin supplements may significantly increase the bioavailability and blood levels of other compounds and medications beyond just curcumin [1][8]. Products containing piperine warrant additional caution regarding drug interactions.

Chemotherapy

There is concern that curcumin's antioxidant effects may decrease the efficacy of alkylating chemotherapy drugs (e.g., melphalan), though this has not been reported clinically [138].

Dietary Sources

Turmeric is the primary dietary source of curcumin. Diets high in turmeric typically provide 60-100 mg of curcumin per day [1].

Turmeric Content

Source	Approximate Curcumin Content	Notes
Turmeric powder (1 teaspoon, ~3 g)	~90 mg curcumin	Ground dried rhizome [1]
Curry powder (1 teaspoon)	~15-25 mg curcumin	Turmeric is one of several spices [1]
Fresh turmeric root (1 inch, ~5 g)	~10-15 mg curcumin	Lower bioavailability vs. powder [5]
Yellow mustard (1 tablespoon)	Trace amounts	Turmeric used mainly as colorant
Turmeric tea (1 tea bag, ~750-1,000 mg powder)	<1 mg in brewed tea	99% filtered out by tea bag [1]

Practical Notes

• Turmeric powder is more bioavailable than fresh: Curcuminoids from powder are approximately twice as bioavailable as from freshly grated turmeric when mixed into a high-fat meal [5].
• Cooking reduces curcumin content: Baking reduces curcumin by approximately 48-52%, while making soup retains approximately 71% [19].
• Fat is essential for absorption: Adding turmeric to tea or smoothies without fat provides minimal curcumin absorption. Whole or reduced-fat milk, yogurt, or vegetable/seed oils enhance absorption [1].
• Black pepper enhances absorption: Adding black pepper to turmeric-containing foods increases curcumin bioavailability due to piperine content [1][8].
• Therapeutic doses require supplementation: Dietary turmeric alone (60-100 mg curcumin/day) provides well below the doses used in most clinical studies (500-2,000+ mg curcuminoids/day) [1].

References

[1] ConsumerLab. "Turmeric and Curcumin Supplements Review." Accessed 2025. https://www.consumerlab.com/reviews/turmeric-curcumin-supplements-spice-review/turmeric/

[2] National Center for Complementary and Integrative Health (NCCIH). "Turmeric." Updated April 2025. https://www.nccih.nih.gov/health/turmeric

[3] Nelson KM, et al. "The Essential Medicinal Chemistry of Curcumin." J Med Chem. 2017;60(5):1620-1637. doi: 10.1021/acs.jmedchem.6b00975

[4] Suresh D, et al. "Curcumin Bioavailability: Structure, Properties and Formulation Strategies." CrystEngComm. 2018.

[5] Nasef NA, et al. "Bioavailability of curcumin from turmeric versus curcumin." Food Funct. 2019.

[6] Jamwal R. "Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers." J Integr Med. 2018;16(6):367-374. doi: 10.1016/j.joim.2018.07.001

[7] Flory S, et al. "Influence of curcumin formulation on the bioaccessibility, metabolism, and bioavailability of curcumin." Mol Nutr Food Res. 2021;65(19):e2100613. doi: 10.1002/mnfr.202100613

[8] Shoba G, et al. "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers." Planta Med. 1998;64(4):353-356. doi: 10.1055/s-2006-957450

[9] Antony B, et al. "A pilot cross-over study to evaluate human oral bioavailability of BCM-95 CG (Biocurcumax)." Indian J Pharma Sci. 2008;70(4):445-449. doi: 10.4103/0250-474X.44591

[10] Cuomo J, et al. "Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation." J Nat Prod. 2011;74(4):664-669. doi: 10.1021/np1007262

[11] Panahi Y, et al. "Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease." Drug Res (Stuttg). 2017;67(4):244-251. doi: 10.1055/s-0043-100019

[12] Cox KH, et al. "Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population." J Psychopharmacol. 2014;29(5):642-651. doi: 10.1177/0269881114552744

[13] Sasaki H, et al. "Innovative preparation of curcumin for improved oral bioavailability." Biol Pharm Bull. 2011;34(5):660-665. doi: 10.1248/bpb.34.660

[14] Jager R, et al. "Comparative absorption of curcumin formulations." Nutr J. 2014;13:11. doi: 10.1186/1475-2891-13-11

[15] Kothaplly RK, et al. "Pharmacokinetic evaluation of a novel turmeric extract." Adv Ther. 2023. doi: 10.1007/s12325-023-02544-4

[16] Kumar D, et al. "Enhanced bioavailability and relative distribution of free (unconjugated) curcuminoids following the oral administration of a food-grade formulation with fenugreek dietary fibre." J Funct Foods. 2016;22:578-587. doi: 10.1016/j.jff.2016.01.039

[17] Panda SK, et al. "A randomized, double blind, crossover, pharmacokinetic bioavailability clinical study." Medicine (Baltimore). 2021;100(11):e24834. doi: 10.1097/MD.0000000000024834

[18] Gurley BJ, et al. "Curcuminoid content and bioavailability of turmeric supplements." Pharm Biol. 2026.

[19] Mahale J, et al. "Effect of food preparation on the curcumin content of turmeric." Mol Nutr Food Res. 2018.

[20] Panahi Y, et al. "Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial." Phytother Res. 2014;28(11):1625-1631. doi: 10.1002/ptr.5174

[21] Haroyan A, et al. "Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis." BMC Complement Altern Med. 2018;18(1):7. doi: 10.1186/s12906-017-2062-z

[22] Henrotin Y, et al. "Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain." Arthritis Res Ther. 2019;21(1):179. doi: 10.1186/s13075-019-1960-3

[23] Jagtap S, et al. "CurcuWin Ultra+ for pain relief in knee osteoarthritis." J Orthop Res Ther. 2023.

[24] Lopresti AL, et al. "Efficacy of curcumin supplements in knee osteoarthritis." Nutrients. 2022. doi: 10.3390/nu14030636

[25] Srivastava S, et al. "Curcumin supplementation in knee osteoarthritis patients on diclofenac." Inflammopharmacology. 2016;24(6):377-388. doi: 10.1007/s10787-016-0289-9

[26] Kuszewski JC, et al. "No effect of curcumin or fish oil on chronic pain, blood flow, or cognition." Rheumatol Adv Pract. 2020. / Kuszewski JC, et al. "Curcumin and fish oil in sedentary obese adults." Nutr Metab Cardiovasc Dis. 2020.

[27] Madhu K, et al. "Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis." Inflammopharmacology. 2013;21(2):129-136. doi: 10.1007/s10787-012-0163-3

[28] Wang Z, et al. "Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis." Ann Intern Med. 2020;173(11):861-869. doi: 10.7326/M20-0990

[29] Nakagawa Y, et al. "Effects of curcumin on knee cartilage repair after surgery." Arthroscopy. 2022. doi: 10.1016/j.arthro.2022.01.002

[30] Feng J, et al. "Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis." BMC Complement Med Ther. 2022;22(1):276. doi: 10.1186/s12906-022-03757-w

[31] Hsiao AF, et al. "The efficacy of high- and low-dose curcumin in knee osteoarthritis." Complement Ther Med. 2021;63:102775. doi: 10.1016/j.ctim.2021.102775

[32] Hidayat R, et al. "Efficacy of Curcuma longa in relieving pain symptoms of knee osteoarthritis patients." J Rheum Dis. 2025;32(1):17-29. doi: 10.4078/jrd.2024.0065

[33] Chandran B, Goel A. "A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis." Phytother Res. 2012;26(11):1719-1725. doi: 10.1002/ptr.4639

[34] Pourhabibi-Zarandi F, et al. "Curcumin supplementation in rheumatoid arthritis." Phytother Res. 2024. doi: 10.1002/ptr.8073

[35] Deodhar SD, et al. "Preliminary study on antirheumatic activity of curcumin." Indian J Med Res. 1980;71:632-634.

[36] Bhat S, et al. "Effect of curcumin on maintenance of remission in rheumatoid arthritis." Rheumatol Int. 2023. doi: 10.1007/s00296-023-05392-5

[37] Kare R, et al. "Turmeric-boswellia formulation for acute low-back pain." Pharmacognosy Mag. 2025.

[38] Gupta R, et al. "Turmeric-boswellia for posture-related low-back pain." J Back Musculoskelet Rehabil. 2025.

[39] Majumdar S, et al. "Turmeric-boswellia formulation for chronic low-back pain." Explore (NY). 2025.

[40] Thamlikitkul V, et al. "Randomized double blind study of Curcuma domestica Val for dyspepsia." J Med Assoc Thai. 1989;72(11):613-620.

[41] Yongwatana K, et al. "Curcumin versus omeprazole for functional dyspepsia." J Gastroenterol Hepatol. 2021. doi: 10.1111/jgh.15580

[42] Kongkam P, et al. "Curcumin vs. omeprazole for functional dyspepsia." BMJ Evid Based Med. 2023. doi: 10.1136/bmjebm-2022-112231

[43] Lopresti AL, et al. "Curcugen for digestive symptoms." BMC Complement Med Ther. 2021. doi: 10.1186/s12906-021-03388-x

[44] Lang A, et al. "Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis." Clin Gastroenterol Hepatol. 2015;13(8):1444-1449. doi: 10.1016/j.cgh.2015.02.035

[45] Masoodi M, et al. "Curcumin nanomicelles and ulcerative colitis." J Cell Biochem. 2018. doi: 10.1002/jcb.27161

[46] Hanai H, et al. "Curcumin maintenance therapy for ulcerative colitis." Clin Gastroenterol Hepatol. 2006;4(12):1502-1506. doi: 10.1016/j.cgh.2006.08.008

[47] Kedia S, et al. "Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis." World J Gastrointest Pharmacol Ther. 2017;8(2):147-154. doi: 10.4292/wjgpt.v8.i2.147

[48] Bommelaer G, et al. "Oral curcumin no more effective than placebo in preventing recurrence of Crohn's disease after surgical resection." Clin Gastroenterol Hepatol. 2019. doi: 10.1016/j.cgh.2019.05.011

[49] Cruz-Correa M, et al. "Curcumin for familial adenomatous polyposis." Gastroenterology. 2018.

[50] Tanabe Y, et al. "Curcumin supplementation for exercise-induced muscle damage." Scand J Med Sci Sports. 2018. doi: 10.1111/sms.13373

[51] Drobnic F, et al. "Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva)." J Int Soc Sports Nutr. 2014;11:31. doi: 10.1186/1550-2783-11-31

[52] Nicol LM, et al. "Curcumin supplementation likely attenuates delayed onset muscle soreness (DOMS)." Eur J Appl Physiol. 2015;115(8):1769-1777. doi: 10.1007/s00421-015-3152-6

[53] Jager R, et al. "Curcumin supplementation reduces markers of inflammation and muscle damage following exercise." FASEB J. 2017.

[54] Hillman AR, et al. "Supplementation with curcumin reduces muscle soreness and markers of exercise-induced muscle damage." J Diet Suppl. 2021. doi: 10.1080/19390211.2021.1904085

[55] McFarlin BK, et al. "Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin." BBA Clinical. 2016;5:72-78. doi: 10.1016/j.bbacli.2016.02.003

[56] Delecroix B, et al. "Curcumin and piperine supplementation and recovery following exercise-induced muscle damage." J Sports Sci Med. 2017;16(1):147-153.

[57] Raj S, et al. "Turmacin for knee pain during exercise." J Diet Suppl. 2023.

[58] Lee MS, et al. "Turmeric improves post-prandial working memory in pre-diabetes." Asia Pac J Clin Nutr. 2014;23(4):581-585. doi: 10.6133/apjcn.2014.23.4.24

[59] Small GW, et al. "Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults." Am J Geriatr Psychiatry. 2017;26(3):266-277. doi: 10.1016/j.jagp.2017.10.010

[60] Santos-Parker JR, et al. "Curcumin supplementation does not improve vascular or cognitive function in healthy older adults." Nutr Healthy Aging. 2018. doi: 10.3233/NHA-180054

[61] Rainey-Smith SR, et al. "Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults." Br J Nutr. 2016;115(12):2106-2113. doi: 10.1017/S0007114516001203

[62] Baum L, et al. "Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease." J Clin Psychopharmacol. 2008;28(1):110-113. doi: 10.1097/jcp.0b013e318160862c

[63] Ringman JM, et al. "Oral curcumin for Alzheimer's disease." Alzheimers Res Ther. 2012;4(5):43. doi: 10.1186/alzrt146

[64] Hishikawa N, et al. "Effects of turmeric on Alzheimer's disease with behavioral and psychological symptoms of dementia." Ayu. 2012;33(4):499-504. doi: 10.4103/0974-8520.110524

[65] Goozee KG, et al. "Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease." Br J Nutr. 2015;115(3):449-465. doi: 10.1017/S0007114515004687

[66] Lopresti AL, et al. "Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study." J Affect Disord. 2014;167:368-375. doi: 10.1016/j.jad.2014.06.001

[67] Lopresti AL, et al. "Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers." J Affect Disord. 2016;199:261-268.

[68] Kanchanatawan B, et al. "Add-on treatment with curcumin has antidepressive effects in Thai patients with major depression." Neurotox Res. 2018;33(3):621-633. doi: 10.1007/s12640-017-9860-4

[69] Yaikwawong M, et al. "Curcumin supplementation for depression in type 2 diabetes." Nutrients. 2024. doi: 10.3390/nu16020173

[70] Shabani N, et al. "Curcumin supplementation in postmenopausal women." BMJ Open. 2025. doi: 10.1136/bmjopen-2024-089774

[71] Thota RN, et al. "Curcumin reduces post-prandial glycaemia and insulinaemia." Sci Rep. 2018;8(1):13025. doi: 10.1038/s41598-018-31588-2

[72] Thota RN, et al. "Curcumin supplementation reduces insulin resistance and GSK-3 beta." Nutrients. 2020. doi: 10.3390/nu12082748

[73] Chuengsamarn S, et al. "Curcumin extract for prevention of type 2 diabetes." Diabetes Care. 2012;35(11):2121-2127. doi: 10.2337/dc12-0116

[74] Funamoto M, et al. "Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels." J Diabetes Res. 2019. doi: 10.1155/2019/8507524

[75] Neta FI, et al. "Effects of curcumin with piperine on glycemic control in type 2 diabetes." Int J Food Sci Nutr. 2021. doi: 10.1080/09637486.2020.1850650

[76] Yaikwawong M, et al. "Curcumin supplementation in type 2 diabetes on metformin." Nutr J. 2024. doi: 10.1186/s12937-024-00939-7

[77] El-Rakabawy NR, et al. "Turmeric supplementation and cardiovascular risk in type 2 diabetes." Sci Rep. 2025. doi: 10.1038/s41598-025-85200-5

[78] He HJ, et al. "Curcumin supplementation for non-alcoholic fatty liver disease." Am J Clin Nutr. 2024. doi: 10.1016/j.ajcnut.2024.07.017

[79] Panahi Y, et al. "Efficacy of curcumin on NAFLD: a randomized clinical trial." J Cell Biochem. 2019. doi: 10.1002/jcb.29015

[80] Sharifi N, et al. "Curcumin supplementation in non-alcoholic fatty liver disease." Phytother Res. 2023. doi: 10.1002/ptr.7684

[81] Musso G, et al. "Curcumin for NASH: a randomized placebo-controlled trial." Hepatology. 2024. doi: 10.1097/HEP.0000000000000808

[82] Hellmann PH, et al. "Curcumin supplementation in obese individuals with fatty liver." Diabetes Obes Metab. 2022. doi: 10.1111/dom.14681

[83] Ebrahimzadeh A, et al. "Curcumin effects on NAFLD: a systematic review and meta-analysis." Complement Ther Med. 2024;80:103025.

[84] Lukkunaprasit T, et al. "Meta-analysis of curcumin on MAFLD." Sci Rep. 2023;13(1):5824.

[85] Malik A, Malik M. "Effects of curcumin in patients with non-alcoholic fatty liver disease." Can Liver J. 2024;7(2):299-315.

[86] Molani-Gol R, et al. "Curcumin/turmeric supplementation in NAFLD: an umbrella meta-analysis." Phytother Res. 2024;38(2):539-555.

[87] Sahebkar A. "Are curcuminoids effective C-reactive protein-lowering agents in clinical practice?" Clin Nutr. 2014;33(1):1-7.

[88] Mohammadi A, et al. "Curcumin with or without probiotics for metabolic syndrome." Food Sci Nutr. 2023. doi: 10.1002/fsn3.3098

[89] Qin S, et al. "Efficacy and safety of turmeric and curcumin in lowering blood lipid levels." Nutr J. 2017;16(1):68. doi: 10.1186/s12937-017-0293-y

[90] Ferguson JJA, et al. "Curcumin potentiates cholesterol-lowering effects of phytosterols." Metabolism. 2017;75:27-35. doi: 10.1016/j.metabol.2017.08.004

[91] Laffin LJ, et al. "Efficacy and Safety of Supplements Compared With Rosuvastatin for Hypercholesterolemia." J Am Coll Cardiol. 2023;82(14):1416-1428. doi: 10.1016/j.jacc.2023.08.003

[92] Akazawa N, et al. "Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women." Nutr Res. 2012;32(10):795-799. doi: 10.1016/j.nutres.2012.09.002

[93] Khajehdehi P, et al. "Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis." J Renal Nutr. 2012;22(1):50-57. doi: 10.1053/j.jrn.2011.03.002

[94] Mousavi SM, et al. "The effect of curcumin supplementation on body weight, BMI and waist circumference." Crit Rev Food Sci Nutr. 2018;60(1):171-183. doi: 10.1080/10408398.2018.1517724

[95] Martins ND, et al. "Curcumin supplementation in inflammatory bowel disease and body composition." Eur J Nutr. 2025. doi: 10.1007/s00394-025-03509-3

[96] Carroll RE, et al. "Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia." Cancer Prev Res (Phila). 2011;4(3):354-364. doi: 10.1158/1940-6207.CAPR-10-0098

[97] Golombick T, et al. "Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin." Am J Hematol. 2012;87(9):908-911. doi: 10.1002/ajh.23262

[98] Vadhan-Raj S, et al. "Curcumin downregulates NF-kB and COX-2 in myeloma patients." Blood. 2007;110(11):1180.

[99] Zaidi A, et al. "Myeloma and curcumin: a case report." BMJ Case Rep. 2017. doi: 10.1136/bcr-2016-218148

[100] Dhillon N, et al. "Phase II trial of curcumin in patients with advanced pancreatic cancer." Clin Cancer Res. 2008;14(14):4491-4499. doi: 10.1158/1078-0432.CCR-08-0024

[101] Passildas-Jahanmohan J, et al. "Curcumin plus docetaxel for metastatic castration-resistant prostate cancer." Cancer Med. 2021. doi: 10.1002/cam4.3893

[102] Kia SJ, et al. "Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucositis." BMC Complement Med Ther. 2021;21(1):232.

[103] Ramezani V, et al. "Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis." BMC Cancer. 2023;23(1):354.

[104] Wu CF, et al. "Efficacy of turmeric in the treatment of oral mucositis in patients with head and neck cancer." Front Pharmacol. 2024;15:1363202.

[105] Gioia C, et al. "Lutein, zeaxanthin, curcumin, and vitamin D3 for moderate dry eye disease." Front Ophthalmol. 2024. doi: 10.3389/fopht.2024.1344592

[106] Alsoudi AF, et al. "Association of turmeric/curcumin supplement use with age-related macular degeneration." JAMA Ophthalmol. 2024. doi: 10.1001/jamaophthalmol.2024.2288

[107] Pia C, et al. "Curcumin for chronic anterior uveitis." Clin Ophthalmol. 2010;4:1201-1206. doi: 10.2147/OPTH.S13271

[108] Wu S, et al. "Curcumin for allergic rhinitis." Ann Allergy Asthma Immunol. 2016;117(6):697-702. doi: 10.1016/j.anai.2016.09.432

[109] Kuwabara T, et al. "Curcumin for common cold prevention." J Diet Suppl. 2023. doi: 10.1080/19390211.2022.2149835

[110] Manarin G, et al. "Curcuma longa as adjuvant treatment of persistent asthma in children and adolescents." J Ethnopharmacol. 2019;238:111882. doi: 10.1016/j.jep.2019.111882

[111] Bupparenoo P, et al. "Effect of curcumin on serum uric acid." J Diet Suppl. 2021. doi: 10.1080/19390211.2020.1862068

[112] Ghodsi H, et al. "Effect of nanocurcumin on Parkinson's disease." Clin Neurol Neurosurg. 2022;215:107177. doi: 10.1016/j.clineuro.2022.107177

[113] Kurd SK, et al. "Oral curcumin in the treatment of moderate to severe psoriasis vulgaris." J Am Acad Dermatol. 2008;58(4):625-631. doi: 10.1016/j.jaad.2007.12.035

[114] Segura-Borrego MP, et al. "Effect of spices on perceived saltiness." J Sci Food Agric. 2024.

[115] Lao CD, et al. "Dose escalation of a curcuminoid formulation." BMC Complement Altern Med. 2006;6:10. doi: 10.1186/1472-6882-6-10

[116] Lukfahr AL, et al. "Drug-induced liver injury from turmeric." BMJ Case Rep. 2018. doi: 10.1136/bcr-2018-224611

[117] Halegoua-DeMarzio D, et al. "Liver injury associated with turmeric — a growing problem: ten cases from the Drug-Induced Liver Injury Network [DILIN]." Am J Med. 2023;136(2):200-206. doi: 10.1016/j.amjmed.2022.09.026

[118] Papke ME Jr, et al. "Turmeric-related liver injury: histopathologic analysis." Histopathology. 2024. doi: 10.1111/his.15055

[119] Likhitsup A, et al. "Estimated exposure to 6 potentially hepatotoxic botanicals in US adults." JAMA Netw Open. 2024;7(8):e2425822.

[120] Zhang Y, et al. "Semaglutide and turmeric-induced liver injury." Am J Hosp Med. 2024.

[121] Rasyid A, et al. "Effect of different curcumin dosages on human gall bladder." Asia Pac J Clin Nutr. 2002;11(4):314-318.

[122] Tang M, et al. "Effect of cinnamon and turmeric on urinary oxalate excretion." Am J Clin Nutr. 2008;87(5):1262-1267. doi: 10.1093/ajcn/87.5.1262

[123] Abdel-Razeq H, et al. "Turmeric-induced yellow skin discoloration." Cureus. 2021. doi: 10.7759/cureus.15624

[124] Horev L, et al. "Yellow discoloration of skin from turmeric supplementation." Drug Saf Case Rep. 2015. doi: 10.1007/s40800-015-0015-x

[125] Smith TJ. "Iron deficiency anemia associated with high-dose turmeric." Cureus. 2019. doi: 10.7759/cureus.3858

[126] Lorinczova HT, et al. "Co-Administration of Iron and a Bioavailable Curcumin Supplement Increases Serum Iron in Healthy Adults." Nutrients. 2021. doi: 10.3390/nu13062084

[127] Sugito T, et al. "Turmeric and tooth staining." Oper Dent Endodontol Periodontol. 2023. / Taneja S, et al. "Staining potential of turmeric solution." J Conserv Dent. 2018.

[128] Daveluy A, et al. "Probable interaction between turmeric and an anticoagulant." Therapie. 2014;69(2):162-164. doi: 10.2515/therapie/2014017

[129] Ghusn W, et al. "Turmeric/fenugreek supplement and excessive bleeding during colonoscopy." Gastroenterology. 2023.

[130] Neerati P, et al. "Curcumin enhanced the bioavailability and antidiabetic activity of glyburide." Phytother Res. 2014;28(12):1796-1800. doi: 10.1002/ptr.5201

[131] Nayeri A, et al. "Tacrolimus toxicity associated with turmeric intake." Transplant Proc. 2017;49(10):2396-2398. doi: 10.1016/j.transproceed.2017.09.012

[132] Pochet L, et al. "Bortezomib-curcumin interaction." Sci Rep. 2022. doi: 10.1038/s41598-022-09469-2

[133] Mir O, et al. "Interaction between curcumin and everolimus." Ann Oncol. 2017.

[134] Hussaarts KGAM, et al. "Impact of curcumin on tamoxifen pharmacokinetics." Cancers. 2019;11(3):403. doi: 10.3390/cancers11030403

[135] Juan H, et al. "Curcumin decreases talinolol bioavailability." Eur J Clin Pharmacol. 2007.

[136] Kushuhara H, et al. "Possible interaction between curcumin and sulfasalazine." Br J Pharmacol. 2012.

[137] Bachhav SS, et al. "Curcumin increases oral testosterone bioavailability." Drug Metab Dispos. 2025.

[138] Brokaar JA, et al. "Potential interaction between curcumin and alkylating chemotherapy agents." Explor Res Clin Soc Pharm. 2025.